Post-HSCT Medication Adherence mHealth App

Through a mixed methods, quasi-experimental design, the study will first focus on developing a mobile health (mHealth) adherence application and evaluating usability and acceptability of the app among caregivers of children in the acute phase post-HSCT. The purpose of this project is to explore the feasibility and acceptability of a mHealth application through user testing and thematic content analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stem Cell Transplantation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

English-speaking
>18 years of age

Exclusion criteria

Caregivers with developmental delays or conditions that make processing and responding to verbal questions challenging/frustrating either online or in a group forum

Treatment and study plan

mHealth adherence app

Behavioral

The mHealth app is designed to remind caregivers to give medication in the outpatient setting, track adherence, and capture real time barriers to adherence if medication is missed.

Primary outcomes

System Usability Scale (SUS)

Time frame: Baseline to day 100

The SUS is a 10-item questionnaire used to evaluate the functionality and acceptability of mHealth apps. Items are rated on a 5 point scale and final scores on the measure range from 0 to 100. Higher scores represent better functionality and acceptability. Scores of > 68 are considered above average.

Sponsors and collaborators

Lead sponsor

Micah Skeens

Other

Collaborators

National Institute of Nursing Research (NINR)

Registry information

Official study title

Design and Feasibility of mHealth App for Pediatric Medication Adherence Post-discharge for Hematopoietic Stem Cell Transplant

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Jul 26, 2021
Registry last updated: Feb 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed